Good day to all. Wanted to ask if somebody has

Good day to all.

Wanted to ask if somebody has come across the totality of the L.H. data that was unblinded (for the 24 symptoms)?. If I recall NP said it was going to be released,

From the June 21st webcast presentation we have data from Join Pain & Swelling, Tightness in Chest, Tingling or Numbness, Muscle Weakness, Sleep Disturbance (Insomnia),Headache, Shortness of Breath and Nausea

Also:

Quote:

---

Clinically meaningful improvements in leronlimab over placebo were observed for cough, stuffy/runny nose, shortness of breath, tightness of chest, feeling of fast heartbeat, fatigue, muscle aches/cramps, muscle weakness, joint pain/swelling, chills/shivering, feeling hot or feverish, difficulty in concentration, sleep disturbance/insomnia, headache, dizziness, tingling/numbness, sense of taste, and sense of smell.

---

and:

Quote:

---

Of the remaining 6 symptoms, sore throat, exertional malaise, anxiety, nausea, and vomiting had no clinically meaningful change. Diarrhea was worse in leronlimab treated compared to placebo.

---

There are only 56 patients but 24 symptoms with 4 degrees of "seriousness" would provide good data and I think some significant conclusions could be drawn form the whole set. The presentation data obviously shows high statistical significance, however, for purely curiosity and investment purposes I would like to run some analysis in the full set with the assumption that these are "all are equal" and non-correlated (this, of course likely not truth).

We will be having news soon about the mTNBC initial results. This, imo will be eventually the big price, if it pans out. Any morsel of signal should be big needle mover.

In the mean time, I hope you are all accumulating shares as I am .